Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

20. Novembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2878


	Articles 1 - 20 / 57554

	5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA. Commun Biol Xue Y, Ning Y, Friedl V, Haan D, Bergamaschi A, Guler GD, Hazen K, Scott A, Phillips T, McCarthy E, Ellison CK, Malta R, Nguyen A, Lopez V, Cavet R, Peters M, Sheard J, Gibb W, Chowdhury S, Volkmuth W, Levy S. PMID: 41261178 [PubMed - indexed for MEDLINE]
	Prognostic Value of Composite Inflammatory Prognostic Model in Pancreatic Cancer. Mol Cell Probes Wei Q, Li Z, Feng H, Zhang J, Wei L. PMID: 41260275 [PubMed - as supplied by publisher]
	zDHHC-mediated palmitoylation modification patterns and tumor immune microenvironment infiltration characterization in pancreatic cancer. Int Immunopharmacol Lu C, He Y, Zhang LQ, Miao JY, Wang W. PMID: 41260168 [PubMed - as supplied by publisher]
	Clinical Implications of Dihydropyrimidine Dehydrogenase Deficiency in GI and Hepatopancreaticobiliary Cancers Treated With Fluoropyrimidines: A Prospective Observational Study. JCO Glob Oncol Goel V, Basu DA, Jain A, Patnaik N, Jaju A, Mehta A, Talwar V. PMID: 41259730 [PubMed - indexed for MEDLINE]
	DNA methylation-mediated ADA overexpression drives pancreatic cancer progression. Discov Oncol Zeng J, Jiao J, Lin B, Li H, Xu W. PMID: 41258527 [PubMed - as supplied by publisher]
	Risk of all-cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network. Cardiovasc Diabetol Tartaglia E, Bucci T, Rossi M, Rigutini AG, Askarinejad A, Alam U, Nabrdalik K, Boriani G, Lip GYH. PMID: 41257737 [PubMed - indexed for MEDLINE]
	Global, regional, and national burden and trends of pancreatic cancer, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Front Oncol Liu C, Liu P, Liu X, Niu W, Wu P, Yu J. PMID: 41256325 [PubMed]
	Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial. Commun Med (Lond) Topal H, Venken T, Bassez A, Chiritescu G, Van Cutsem E, van der Merwe S, Lambrechts D, Topal B. PMID: 41254229 [PubMed]
	Stereotactic body radiotherapy versus laparoscopic liver resection for single hepatocellular carcinomaâ€‰â‰¤â€‰5Â cm: a retrospective, multicenter, cohort study. Sci Rep Zhou B, Ma Z, Cheng X, Yan M, Duan Y, Ye J, Guo L, Xue J, Meng Y, Cheng S, Guo W. PMID: 41254049 [PubMed - indexed for MEDLINE]
	Migrasome-related LncRNA features predict immune microenvironment and prognosis in pancreatic cancer. Sci Rep Li W, Cao Y, Sun X, Wang T, Xu P, Li P. PMID: 41253932 [PubMed - indexed for MEDLINE]
	Endoscopic ultrasound features of pancreatic serous cystic neoplasms: a single-center experience. Med Ultrason Liu JH, Fan CX, Jiang FX, Xie XX, Guo YY, Wang R. PMID: 41252616 [PubMed - as supplied by publisher]
	A Phase I/II Study Protocol of a Novel Neoadjuvant 'PRaG' Regimen (Radiotherapy, GM-CSF, and Cadonilimab) with AG Chemotherapy to Improve Resectability in Locally Advanced Pancreatic Ductal Adenocarcinoma: The NeoPRAG Study. Technol Cancer Res Treat Xu M, Zhang J, Kong Y, Xing P, Zhao X, Chen R, Pu Y, Chen W, Zhang L. PMID: 41252443 [PubMed - indexed for MEDLINE]
	Comprehensive Evaluation of Lipids, Lipoproteins, and Metabolites Associated with Gastrointestinal Cancer Risk. Cancer Epidemiol Biomarkers Prev Sun M, Chen W, Cheng X, Cui H, Huang J, Huang R, Li Y, Ma Y, Hang D. PMID: 41252339 [PubMed - as supplied by publisher]
	The Role of PI3K Inhibition in Suppressing Pancreatic Cancer Progression: Mechanistic Insights From Copanlisib Studies. Arch Pharm (Weinheim) Yu L, Wu J, Wan S, Zhu J. PMID: 41251088 [PubMed - indexed for MEDLINE]
	Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol. BMJ Open Wilding S, Goss V, Sukdao W, Hamady Z, Lord J, Coleman A, Pointer C, Walters J, Herbert W, Mclaughlin K, Waugh R, Irvine N, Oliver T, Soulsby I, Hooper J, Crabb SJ, Griffiths G, Yates E, Davies A. PMID: 41248417 [PubMed - indexed for MEDLINE]
	Pancreatic findings in participants in a program of low-dose computed tomography screening for lung cancer. Eur J Cancer Prev Gros L, Yip R, Zhu Y, Li P, Paksashvili N, Sun Q, Yankelevitz DF, Henschke CI. PMID: 41247705 [PubMed - as supplied by publisher]
	Tumor regression grade predicts recurrence-free survival in intermediate-advanced hepatocellular carcinoma after conversion therapy. Front Immunol Zhang H, Yang T, Huang L, Li B, Xu H, Wei Y. PMID: 41246344 [PubMed - indexed for MEDLINE]
	Clinical and Molecular Predictors of Response and Survival in Patients with Urothelial Carcinoma Treated with Enfortumab Vedotin: A Systematic Review and Meta-analysis. Eur Urol Open Sci Altenni M, Fehérvári P, Hoferica J, Hegyi P, Ács N, Fazekas T, Vargha J, Grünwald V, Darr C, Riesz P, Nyirády P, Szarvas T. PMID: 41246033 [PubMed]
	Advances in Cancer Vaccines for Digestive System Cancers: A Systematic Analysis of Clinical Trials. Cancer Manag Res Li J, Wang P. PMID: 41245584 [PubMed]
	Salivary biomarkers in cancer detection and management. Acta Biochim Pol Munsif A, Nowaczyk A, Fija, Riaz S, Jamil A. PMID: 41245374 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57554

Page 1 de 2878



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité